Person: Frank Holler

Frank Holler

Frank Holler has joined the board of directors for Genome British Columbia. Holler is currently CEO and fund manager for BC Advantage Funds and has been a prominent executive for several biotechnology firms and has extensive experience in the banking industry. He was president and CEO of both ID Biomedical Corp and Zenon Genetics Inc…

Dr Arnold Naimark

Dr Arnold Naimark has been appointed chair of Health Canada’s science advisory board for a three-year term. He replaces Dr Linda Lusby who has chaired the board in an acting capacity for the past year following the resignation of Dr Judith Hall in 2004. Naimark had a long and distinguished career at the Univ of…

Dr Janusz Kozinski

Dr Janusz Kozinski has been appointed associate VP research at McGill Univ with responsibility for research policy development, industrial research partnerships and overseeing several research services. Kosinski joined McGill in 1994 and is currently the leader of a multidisciplinary team that includes researchers from medicine, chemistry, biotechnology and engineering. He holds a masters of engineering…

Nicholas Ignatieff

Nicholas Ignatieff has been appointed the first director of McGill Univ’s Strategic University Research Funding (SURF) office, which handles McGill proposals to the Canada Foundation for Innovation and other major research initiatives. He previously headed McGill’s Agile All-Photonic Networks initiative and coordinated the Centre for Advanced Systems and Technologies in Communications. He was also director…